Nanoform Finland Oyj (NANOFH.HE)
Nanoform Finland Oyj operates in the Biotechnology industry of the Healthcare sector, headquartered in Helsinki, UU, FI. The stock last traded at $1.00, down 2.91% on the session, giving a market capitalisation of $85.7M. Its beta of 0.78 implies it has historically moved less than the broad market.
Helsinki, Finland-based Nanoform Finland Oyj provides advanced nanotechnology and drug particle engineering solutions for the pharmaceutical sector across Europe and the United States. The company specializes in the production of nanoparticles, utilizing its exclusive "controlled expansion of supercritical solutions" technology, which aids its clients in their development processes. Nanoform was established in 2008.
Nanoform Finland Oyj is most often compared with the following Healthcare names: